Form 4 for BCDA BioCardia, Inc.

Accepted 2025-09-23 00:00:00 ET · period of report 2025-09-19 · accession 0001437749-25-029653 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2025-09-23	2025-09-19	BCDA	STERTZER SIMON H	Dir	P - Purchase	$1.25	+398.4K	591.1K	+207%	+$498.0K
DI	2025-09-23	2025-09-19	BCDA	STERTZER SIMON H	Dir	P - Purchase	—	+398.4K	575.7K	+225%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-09-19	P	A	398,400	$1.25	591,054	I See Footnote	—	—	(F1) These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. (F3) These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers.
2	Derivative	Warrant (right to buy)	2025-09-19	P	A	398,400	—	575,675	I See Footnote	$1.25 · 2025-09-19 to 2027-09-20	398,400 Common Stock	(F1) These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. (F2) These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.